MIM
Monashee Investment Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-888,888
| Closed | -$1.36M | – | 41 |
|
|
2025
Q1 | $1.36M | Hold |
888,888
| – | – | 0.16% | 45 |
|
|
2024
Q4 | $2.2M | Buy |
+888,888
| New | +$2.2M | 0.3% | 27 |
|
|
2021
Q3 | – | Sell |
-100,000
| Closed | -$1.76M | – | 266 |
|
|
2021
Q2 | $1.76M | Buy |
+100,000
| New | +$1.76M | 0.21% | 141 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 142 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 61 |
|
|
2017
Q3 | – | Sell |
-45,740
| Closed | -$1.24M | – | 43 |
|
|
2017
Q2 | $1.24M | Buy |
+45,740
| New | +$1.24M | 0.52% | 51 |
|
|
2017
Q1 | – | Sell |
-126,700
| Closed | -$3.44M | – | 56 |
|
|
2016
Q4 | $3.44M | Buy |
+126,700
| New | +$3.44M | 1.67% | 23 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 64 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 18 |
|